Rigel Pharmaceuticals, Inc. (RIGL)
收市後：
| 前收市價 | 1.1250 |
| 開市 | 1.1200 |
| 買盤 | 1.0800 x 600 |
| 賣出價 | 1.1100 x 600 |
| 今日波幅 | 1.0618 - 1.1300 |
| 52 週波幅 | 0.7100 - 1.9600 |
| 成交量 | |
| 平均成交量 | 1,483,111 |
| 市值 | 192.945M |
| Beta 值 (5 年，每月) | 0.98 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.1400 |
| 業績公佈日 | 2024年4月30日 - 2024年5月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 4.57 |
ZacksSilence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Insider MonkeyRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q4 2023 Earnings Call Transcript March 5, 2024 Rigel Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year 2023. […]
ZacksRigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4
Rigel (RIGL) delivered earnings and revenue surprises of 100% and 0.26%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
